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Previewsreduction in MR S843P compared with
wild-type, despite hyperkalemia which
normally elevates the level of phosphory-
lation. Very high levels of administered
aldosterone (>10-fold those in sodium
deficiency) elevated pendrin and BI H+
ATPase (MR-induced proteins) 2- to 3-
fold; equivalent doses in wild-type mice
produced little or no effect. This is alto-
gether unsurprising, given that the major-
ity of MR S843 were nonphosphorylated
in the transgenic mice; wild-type mice on
regular mouse chow have much higher
MRS843P (and thereforemuch lower levels
of activable MR S843) than the mutants.
I have no doubt that dephosphorylated
MR S843 in intercalated cells can be
activated by aldosterone. The authors
show equivalent activation by cortisol;
without any ‘‘protective’’ mechanism like
11bHSD, the default agonist in vivo is
therefore cortisol (corticosterone in the
mouse). This is not merely a default posi-
tion, but clearly supported by the different
phenotypes of the MR knockout (MRKO)
and the aldosterone synthase null
(AS/) mouse (Funder, 2006). MR are
clearly essential for Na+ homeostasis: on610 Cell Metabolism 18, November 5, 2013 ªa low salt intake, MRKO mice perish.
Aldosterone is not essential; in AS/
mice on a low salt intake, their blood pres-
sure falls slightly, their renin-angiotensin
system is markedly activated, they
become modestly hyperkalemic, but (in
the presence of glucocorticoids) they sur-
vive (Makhanova et al., 2006). Occam’s
razor would say that they are doing this
via their intercalated cells, with the very
elevated angiotensin overcoming the
modest hyperkalemia in terms of dephos-
phorylation of intercalated cell MR S843P,
and endogenous glucocorticoid then
allowing sufficient Na-Cl reabsorption to
maintain life.
The authors’ yoking the discovery of
a single phosphorylation site in the MR
ligand binding domain to solving a physi-
ological (and inevitably, clinical) conun-
drum is a masterstroke of translational
research. By showing the opposite effects
of angiotensin and hyperkalemia on MR
S843 phosphorylation, the authors have
elegantly demonstrated how these two
different stimuli can act via MR to main-
tain electrolyte homeostasis. Given the
absence of 11bHSD2 from intercalated2013 Elsevier Inc.cells, the ligand for dephosphorylated
MR S843 is presumptively cortisol rather
than aldosterone. If this is the case, the
authors have solved not one but two
enigmas. The first is theMR-mediated dif-
ferential response to volume depletion
and potassium loading; the second is
the different response to sodium restric-
tion in the MRKO and AS/ mouse.
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The Nlrp3 inflammasome is a key controller of the proinflammatory cytokine IL-1b. Iyer and colleagues (2013)
demonstrate that Nlrp3 activators promote an interaction between cardiolipin in mitochondria and Nlrp3.
Cardiolipin is thus a hydrophobic danger signal that, upon translocation to the outer mitochondrial mem-
brane, activates Nlrp3, promoting inflammation.The Nlrp3 inflammasome is a multiprotein
complex that regulates caspase-1, the
protease that processes pro-IL-1b into its
mature form. Given the importance of IL-
1b as a proinflammatory cytokine, there
has been interest in understanding the
regulation of Nlrp3. Studies in Nlrp3-defi-
cient mice as well as humans all point
to Nlrp3 as an important driver of inflam-
matory diseases as diverse as type 2
diabetes, Alzheimer’s disease, and gout(Wen et al., 2012). Nlrp3 can be activated
by a wide range of stimuli, including
particles such as uric acid, islet-associ-
ated polypeptide, b-amyloid and silica,
as well as factors such as ATP acting via
the P2X7 receptor. This diversity of stimuli
has presented a challenge concerning the
mechanism of activation. A common fea-
ture appears to be the generation of
reactive oxygen species (ROS) by mito-
chondria (Zhou et al., 2011), althoughhow ROS actually impacts Nlrp3 is not
known. In a recent paper in Immunity, Iyer
and colleagues provide a new piece in the
puzzle of Nlrp3 activation, identifying the
mitochondrial phospholipid cardiolipin
as an activator of Nlrp3, operating down-
stream of ROS (Iyer et al., 2013). Of inter-
est, cardiolipin acts as a classic danger
signal, given that it appears on the outer
membrane of mitochondria only when
the mitochondria become dysfunctional.
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Figure 1. Cardiolipin Activates the Nlrp3 Inflammasome
Both ROS-dependent and -independent activators of Nlrp3 cause cardiolipin to translocate from the inner to the outer mitochondrial membrane. Cardiolipin then
binds to the LRR domain of Nlrp3, explaining why Nlrp3 localizes to the mitochondria. This interaction leads to activation of the Nlrp3 inflammasome, promoting
caspase-1-mediated cleavage of pro-IL-1b to mature IL-1b.
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PreviewsThe study began with an observation
regarding the antibiotic linezolid, which
causes myelosuppression—suppression
of erythroid progenitors in bone
marrow—as a side effect. The authors
wondered if the myelosuppression was
due to a proinflammatory effect induced
by linezolid, since the inflammatory pro-
cess is known to affect the numbers of
erythroid and myeloid precursors. They
found no induction of inflammatory cyto-
kines such as TNF or IL-6 in macro-
phages. However, assaying for IL-1b
production, they observed a strong
increase in the levels of mature IL-1b, an
effect not observed with other antibiotics.
The effect on IL-1b was Nlrp3 dependent
since it was attenuated in Nlrp3-deficient
mice and in mice lacking the inflamma-
some platform protein Asc. Linezolid
also increased neutrophil infiltration into
the peritoneum, which was also Nlrp3
dependent. In the final in vivo experiment,
the authors found that the effect of line-
zolid on myelopoiesis required Nlrp3,
providing a mechanistic basis for this
side effect of linezolid.The authors then explored the mecha-
nism by which linezolid activates Nlrp3.
As with other Nlrp3 activators, activation
by linezolid required an efflux in potas-
sium. However, antioxidants such as
the mitochondrially targeted antioxidant
mito-TEMPO had no effect on the
response, which is of substantial interest
given that all other Nlrp3 activators are
ROS dependent. Consistent with previ-
ous studies showing that linezolid causes
mitochondrial dysfunction, the authors
observed a decrease in NAD+, ATP, and
cytochrome oxidase activity. Indeed,
Cyclosporine A, which prevents the mito-
chondrial membrane permeability transi-
tion, inhibited the response to linezolid,
implicating the membrane permeability
transition in the response.
Since Nlrp3 is known to associate with
mitochondria, the authors tested which
mitochondrial component might bind to
it. To test lipids, they immuoprecipitated
Nlrp3 from 14C-linoleic acid-labeled cells
activated with ATP or silica following
LPS priming (a standard method to
activate Nlrp3 and induce production ofCell Metabolism 18,pro-IL-1b), and observed amajor increase
in cardiolipin binding to Nlrp3. This lipid is
usually found in the inner mitochondrial
membrane and has a unique structure
among phospholipids, containing two
diacylated phosphatidyl groups joined
by a glycerol bridge. Using a protein-lipid
overlay assay, the authors found that
cardiolipin binds to the leucine rich repeat
(LRR) region of Nlrp3. To test the role
of cardiolipin in Nlrp3 activation, the
authors used two different approaches
to decrease cardiolipin levels in cells: (1)
incubation with palmitate in serum-free
medium or (2) knockdown of cardiolipin
synthase. Both of these approaches
interfere with cardiolipin biosynthesis.
Under both scenarios, activation of
Nlrp3 was impaired, as was Nlrp3 binding
to mitochondria. In fact, activation was
impaired with all stimuli tested, both
those that act via ROS, and linezolid,
which does not, indicating that cardiolipin
is essential for Nlrp3 activation. Cardioli-
pin has been shown to be involved in
apoptosis, regulating caspase-8. This
role in apoptosis is separate from itsNovember 5, 2013 ª2013 Elsevier Inc. 611
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Previewseffect on Nlrp3, however, since apoptotic
activators such as staurosporine do not
activate Nlrp3.
This study is important for a number
of reasons. First, the results show that
it is possible to activate Nlrp3 in a
ROS-independent manner, raising the
question as to what other stimuli, more
physiological than linezolid, might
achieve this effect. It appears likely that
any mitochondrial disruptor that causes
cardiolipin to move to the outer mito-
chondrial membrane will activate Nlrp3.
Second, the study shows that cardiolipin
is a common regulator of Nlrp3, whether
ROS is involved or not. Cardiolipin may
therefore be a key downstream player in
the effect of ROS on Nlrp3, although
how ROS might cause cardiolipin translo-
cation needs to be explored. The change
in the mitochondrial membrane perme-
ability transition may be involved in this
translocation. Third, cardiolipin binds to
the LRR of Nlrp3, but the consequences
of this interaction are unclear. Is there a
conformational change that allows cas-612 Cell Metabolism 18, November 5, 2013 ªpase-1 activation in the Nlrp3 inflam-
masome complex? Or, is localization
to the mitochondria sufficient to trigger
activation? One complication is that in
cells containing an active inflammasome,
large specks containing Asc and Nlrp3
form, but not proximal to mitochondria.
The role of mitochondria for the func-
tioning of these specks needs to be
addressed. Finally, the study suggests
that cardiolipin fulfils the criteria of a
hydrophobic danger signal, as first pro-
posed by Seong and Matzinger (2004).
Such a signal would be exposed in
response to stress that triggers mito-
chondrial dysfunction. The study from
Iyer et al. (2013) suggests that inflam-
matory insults caused by infection or
noxious agents such as silica cause
cardiolipin to move from the haven of
the inner mitochondrial membrane
to the cytosol-facing outer membrane,
allowing Nlrp3 recruitment and activation
and leading to the production of the
important proinflammatory cytokine IL-
1b, as shown in Figure 1.2013 Elsevier Inc.The mitochondrion, therefore, yet again
takes center stage as an organelle that
provides a readout for the state of the
cell, in this case via cardiolipin transloca-
tion (Tschopp, 2011). The study therefore
brings us a step closer to understanding
the complex regulation of the Nlrp3
inflammasome, a fascinating multiprotein
complex that is essential for health and
yet must be kept under tight control to
prevent disease.REFERENCES
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Exercise produces many beneficial effects on brain health, in part by increasing hippocampal BDNF
levels; however, the mechanism underlying this BDNF regulation remains unknown. In this issue of Cell
Metabolism, Wrann et al. (2013) show that exercise induces hippocampal Bdnf gene expression by stimu-
lating expression of FNDC5, the precursor of irisin, via the transcriptional complex PGC-1a/Erra.Exercise, especially endurance exercise,
offers many health benefits to the human
brain, including improving cognitive func-
tion, reducing risk for Alzheimer’s dis-
ease, and alleviating depression (Cotman
et al., 2007; Mattson, 2012). These
beneficial effects implicate the hippo-
campus as a major target of exercise, as
the hippocampus is crucial for cognitive
function and is one of the brain regions
severely affected in Alzheimer’s disease
and depression (Duman and Aghajanian,
2012; Huang and Mucke, 2012). Indeed,exercise increases adult neurogenesis in
the dentate gyrus (DG, part of the hippo-
campus), dendritic complexity of DG
granule neurons, and synaptic plasticity
(the cellular basis of learning) in the
pathway connecting the entorhinal cortex
to the DG (Eadie et al., 2005; Farmer et al.,
2004). Substantial evidence indicates that
exercise affects the hippocampus largely
by inducing expression of brain-derived
neurotrophic factor (BDNF) (Mattson,
2012). BDNF is a potent regulator of
neuronal survival, adult neurogenesis,synaptogenesis, and synaptic plasticity
(Park and Poo, 2013). However, the
biochemical pathway that is activated by
exercise and induces Bdnf gene expres-
sion remains unknown. Wrann et al.
(2013) now report identification of a
novel biochemical pathway linking an
exercise-induced, secreted factor from
skeletal muscle to hippocampal Bdnf
gene expression (Figure 1).
Spiegelman and colleagues have
recently discovered that exercise induces
expression of FNDC5, a type I membrane
